| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $23.8M | — | +3406.9% |
| SG&A Expense | $7.0M | — | +266.2% |
| Operating Income | -$30.8M | — | -1085.5% |
| Pre-tax Income | -$27.7M | — | -996.0% |
| Income Tax | $42K | — | +2000.0% |
| Net Income | -$27.8M | — | -996.8% |
| EPS (Basic) | -$0.62 | — | +67.7% |
| EPS (Diluted) | -$0.62 | — | +67.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $532.9M | +106.9% | +4363.5% |
| Current Assets | $535.4M | +105.6% | +3487.8% |
| Total Assets | $535.4M | +105.5% | +3384.8% |
| Current Liabilities | $23.8M | +18.7% | +1435.3% |
| Total Liabilities | $23.8M | +18.3% | +1339.6% |
| Stockholders' Equity | $511.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.6M | — | -744.5% |
| Financing Cash Flow | $295.9M | — | — |
| +3631.9% |